Practice Areas

Education

Bar and Court Admissions

Joseph Lipofsky

Photo of Joseph  Lipofsky
Of Counsel

Since 1995, Mr. Lipofsky has been Of Counsel to Zwerling Schachter. Mr. Lipofsky has been primarily involved in the prosecution of antitrust class actions, including In re Tamoxifen Antitrust Litigation, E.D.N.Y., MDL No. 1408; Karofsky v. Abbott Laboratories, et al., Case No. CV-95-1009 (Super. Ct. Me.) (as well as in 10 related cases in other state courts); In Re Lorazepam and Clorazepate Antitrust Litigation, D.D.C., MDL-1290 (TFH) (as well as in 11 related cases in state courts) (“Mylan”); and In Re Ciprofloxacin Hydrochloride Antitrust Legislation, E.D.N.Y., Master File No. CV-00-4428 MDL No. 1383. Mr. Lipofsky has also been involved in innovative class action settlements providing benefits to community-based organizations. For example, in Mylan, Mr. Lipofsky was the principal attorney interacting with the National Association of Community Health Centers, through which $64 million in pharmaceutical benefits were provided to working poor families. In In re Norvir Abbott Laboratories Antitrust Litigation, N.D. Cal., Case No. 04-1511, Mr. Lipofsky undertook a major role in providing a portion of the settlement benefits to 13 not-for-profit organizations that deliver direct services to people who are HIV positive.



Past Experience

Professional & Community Activities